+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2019

  • ID: 4769198
  • Drug Pipelines
  • 504 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Adrenomed AG
  • BEAT BioTherapeutics Corp
  • CCRP Therapeutics GmbH
  • Juventas Therapeutics Inc
  • Otsuka Holdings Co Ltd
  • resTORbio Inc
  • MORE
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2019

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2019, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape.

Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver or abdomen, swollen feet and ankles and weight gain. There are two types of heart failure including systolic heart failure (left ventricle loses its ability to contract normally) and diastolic heart failure (left ventricle loses its ability to relax normally). The predisposing factors include high blood pressure, diabetes, sleep apnea, alcohol use and irregular heartbeats. Treatment includes surgery, vasodilator, beta blockers and diuretics.

Report Highlights

This latest pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 14, 27, 23, 3, 68 and 19 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 19 and 4 molecules, respectively.

Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Congestive Heart Failure (Heart Failure) (Cardiovascular).
  • The pipeline guide reviews pipeline therapeutics for Congestive Heart Failure (Heart Failure) (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Congestive Heart Failure (Heart Failure) (Cardiovascular) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Congestive Heart Failure (Heart Failure) (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Congestive Heart Failure (Heart Failure) (Cardiovascular)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Congestive Heart Failure (Heart Failure) (Cardiovascular).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Adrenomed AG
  • BEAT BioTherapeutics Corp
  • CCRP Therapeutics GmbH
  • Juventas Therapeutics Inc
  • Otsuka Holdings Co Ltd
  • resTORbio Inc
  • MORE
Introduction

Congestive Heart Failure (Heart Failure) - Overview

Congestive Heart Failure (Heart Failure) - Therapeutics Development

Congestive Heart Failure (Heart Failure) - Therapeutics Assessment

Congestive Heart Failure (Heart Failure) - Companies Involved in Therapeutics Development

Congestive Heart Failure (Heart Failure) - Drug Profiles

Congestive Heart Failure (Heart Failure) - Dormant Projects

Congestive Heart Failure (Heart Failure) - Discontinued Products

Congestive Heart Failure (Heart Failure) - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Congestive Heart Failure (Heart Failure), H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under Development by Universities/Institutes, H1 2019

Number of Products under Development by Universities/Institutes, H1 2019 (Contd..1), H1 2019

Products under Development by Companies, H1 2019

Products under Development by Universities/Institutes, H1 2019

Products under Development by Universities/Institutes, H1 2019 (Contd..1), H1 2019

Number of Products by Stage and Target, H1 2019

Number of Products by Stage and Mechanism of Action, H1 2019

Number of Products by Stage and Route of Administration, H1 2019

Number of Products by Stage and Molecule Type, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Actelion Pharmaceuticals Ltd, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Adrenomed AG, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Amgen Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Araim Pharmaceuticals Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by ARCA biopharma Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Arena Pharmaceuticals Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Ascendia Pharmaceuticals LLC, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Astellas Pharma Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by AstraZeneca Plc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Athersys Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Bayer AG, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by BEAT BioTherapeutics Corp, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Betagenon AB, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by BioCardia Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by BlueRock Therapeutics, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Boehringer Ingelheim GmbH, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Bristol-Myers Squibb Co, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by C&C BioPharma LLC, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Capricor Therapeutics Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Cardiol Therapeutics Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by CCRP Therapeutics GmbH, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Celixir Ltd, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Daiichi Sankyo Co Ltd, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by F. Hoffmann-La Roche Ltd, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Hemostemix Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Immunwork Inc, H1 2019

Congestive Heart Failure (Heart Failure) - Pipeline by Innopharmax Inc, H1 2019

List of Figures

Number of Products under Development for Congestive Heart Failure (Heart Failure), H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under Development by Universities/Institutes, H1 2019

Number of Products by Top 10 Targets, H1 2019

Number of Products by Stage and Top 10 Targets, H1 2019

Number of Products by Top 10 Mechanism of Actions, H1 2019

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019

Number of Products by Top 10 Routes of Administration, H1 2019

Number of Products by Stage and Top 10 Routes of Administration, H1 2019

Number of Products by Top 10 Molecule Types, H1 2019

Number of Products by Stage and Top 10 Molecule Types, H1
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Actelion Pharmaceuticals Ltd
  • Adrenomed AG
  • Amgen Inc
  • Araim Pharmaceuticals Inc
  • ARCA biopharma Inc
  • Arena Pharmaceuticals Inc
  • Ascendia Pharmaceuticals LLC
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Athersys Inc
  • Bayer AG
  • BEAT BioTherapeutics Corp
  • Betagenon AB
  • BioCardia Inc
  • BlueRock Therapeutics
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Co
  • C&C BioPharma LLC
  • Capricor Therapeutics Inc
  • Cardiol Therapeutics Inc
  • CCRP Therapeutics GmbH
  • Celixir Ltd
  • Daiichi Sankyo Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Hemostemix Inc
  • Immunwork Inc
  • Innopharmax Inc
  • Inserm Transfert SA
  • Intra-Cellular Therapies Inc
  • Japan Tobacco Inc
  • Juventas Therapeutics Inc
  • KBP BioSciences Co Ltd
  • La Jolla Pharmaceutical Company
  • Lead Discovery Center GmbH
  • Les Laboratoires Servier SAS
  • Lexicon Pharmaceuticals Inc
  • Merck & Co Inc
  • Mesoblast Ltd
  • Miragen Therapeutics Inc
  • Mitsubishi Tanabe Pharma Corp
  • Moderna Therapeutics Inc
  • MyoKardia Inc
  • NanoCor Therapeutics Inc
  • Novartis AG
  • Otsuka Holdings Co Ltd
  • Oxstem Ltd
  • Palatin Technologies Inc
  • Paradigm Biopharmaceuticals Ltd
  • Pfizer Inc
  • PharmaIN Corp
  • PhaseBio Pharmaceuticals Inc
  • Q BioMed Inc
  • Quantum Genomics SA
  • Recardio GmbH
  • Renova Therapeutics Inc
  • resTORbio Inc
  • Ribomic Inc
  • Saje Pharma LLC
  • Sarfez Pharmaceuticals Inc
  • Senju Pharmaceutical Co Ltd
  • Shenzhen Salubris Pharmaceuticals Co Ltd
  • Shin Poong PharmCo Ltd
  • Sorrento Therapeutics Inc
  • Stemedica Cell Technologies Inc
  • Sun Pharma Advanced Research Company Ltd
  • Takeda Pharmaceutical Co Ltd
  • Theravance Biopharma Inc
  • Toa Eiyo Ltd
  • Torrent Pharmaceuticals Ltd
  • U.S. Stem Cell Inc
  • Vifor Pharma Ltd
  • Windtree Therapeutics Inc
  • XyloCor Therapeutics Inc
  • Zensun (Shanghai) Sci & Tech Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll